Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model

Authors: Xiaoxiao Chen, Qicai Chen, Lili Chen, Pengpeng Zhang, Juan Xiao, Shumei Wang

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

Metabolic Syndrome (MS) is increasingly becoming a major worldwide clinical and public health issue. Thus it is extremely important to study the history of MS and search for the most likely component contributing to start the cascade of confusions of MS.

Methods

A longitudinal cohort was involved which included the data of 7510 individuals who had at least two routine health check-ups in a six-year follow-up. Based on the data, a Markov model with each chain containing seven states (no component state, four isolated states, 2-component state, and MS state) was built. Annual transition probability was the mean of five probabilities for the transition between the given states between each pair of consecutive years.

Results

The transition probabilities from the no component state to MS were higher in men than that in women in four age groups. In the young people (men <60 years and women <50 years), the probabilities to the overweight or obesity state and dyslipidemia state were the first two biggest probabilities in transition from no component to the rest six states. However, in the elderly population, the probabilities to hypertension state and 2-component state increased, even surpassed the above two states. The individuals initiating with 2-component states and the isolated hyperglycemia state were more likely to develop MS than the others.

Conclusions

The Markov model was able to give a better description of the evolutionary history of MS, and to predict the future course based on past evidence. The occurrence of the MS process mostly began with overweight or obesity and dyslipidemia in young people. In the elderly population, many individuals initiating with hypertension or 2 components besides the above two states. Individuals with the isolated hyperglycemia had greater chances to develop MS than other isolated MS’ components.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005, 12 (6): 295-300. 10.5551/jat.12.295.CrossRefPubMed Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005, 12 (6): 295-300. 10.5551/jat.12.295.CrossRefPubMed
2.
go back to reference Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365 (9468): 1415-1428. 10.1016/S0140-6736(05)66378-7.CrossRefPubMed Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365 (9468): 1415-1428. 10.1016/S0140-6736(05)66378-7.CrossRefPubMed
3.
go back to reference Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112 (20): 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112 (20): 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed
4.
go back to reference Grundy SM: Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008, 28 (4): 629-636. 10.1161/ATVBAHA.107.151092.CrossRefPubMed Grundy SM: Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008, 28 (4): 629-636. 10.1161/ATVBAHA.107.151092.CrossRefPubMed
5.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
7.
go back to reference Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhao TM: Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008, 89 (3): 649-655. 10.1016/j.fertnstert.2007.03.081.CrossRefPubMed Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhao TM: Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008, 89 (3): 649-655. 10.1016/j.fertnstert.2007.03.081.CrossRefPubMed
8.
go back to reference Dumas ME, Kinross J, Nicholson JK: Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology. 2014, 146 (1): 46-62. 10.1053/j.gastro.2013.11.001.CrossRefPubMed Dumas ME, Kinross J, Nicholson JK: Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology. 2014, 146 (1): 46-62. 10.1053/j.gastro.2013.11.001.CrossRefPubMed
9.
go back to reference Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23 (5): 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed
10.
go back to reference Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjorngard JH, Manczuk M, Zatonski WA: Metabolic syndrome in Poland - the PONS Study. Ann Agric Environ Med. 2011, 18 (2): 270-272.PubMed Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjorngard JH, Manczuk M, Zatonski WA: Metabolic syndrome in Poland - the PONS Study. Ann Agric Environ Med. 2011, 18 (2): 270-272.PubMed
11.
go back to reference McCullough AJ: Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011, 12 (5): 333-340. 10.1111/j.1751-2980.2010.00469.x.CrossRefPubMed McCullough AJ: Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011, 12 (5): 333-340. 10.1111/j.1751-2980.2010.00469.x.CrossRefPubMed
12.
go back to reference Cuevas A, Alvarez V, Carrasco F: Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes. 2011, 18 (2): 134-138. 10.1097/MED.0b013e3283449167.CrossRefPubMed Cuevas A, Alvarez V, Carrasco F: Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes. 2011, 18 (2): 134-138. 10.1097/MED.0b013e3283449167.CrossRefPubMed
13.
go back to reference Szigethy E, Szeles G, Horvath A, Hidvegi T, Jermendy G, Paragh G, Blasko G, Adany R, Voko Z: Epidemiology of the metabolic syndrome in Hungary. Public Health. 2012, 126 (2): 143-149. 10.1016/j.puhe.2011.11.003.CrossRefPubMed Szigethy E, Szeles G, Horvath A, Hidvegi T, Jermendy G, Paragh G, Blasko G, Adany R, Voko Z: Epidemiology of the metabolic syndrome in Hungary. Public Health. 2012, 126 (2): 143-149. 10.1016/j.puhe.2011.11.003.CrossRefPubMed
14.
go back to reference Wang GR, Li L, Pan YH, Tian GD, Lin WL, Li Z, Chen ZY, Gong YL, Kikano GE, Stange KC, Ni KL, Berger NA: Prevalence of metabolic syndrome among urban community residents in China. BMC Public Health. 2013, 13: 599-10.1186/1471-2458-13-599.CrossRefPubMedPubMedCentral Wang GR, Li L, Pan YH, Tian GD, Lin WL, Li Z, Chen ZY, Gong YL, Kikano GE, Stange KC, Ni KL, Berger NA: Prevalence of metabolic syndrome among urban community residents in China. BMC Public Health. 2013, 13: 599-10.1186/1471-2458-13-599.CrossRefPubMedPubMedCentral
15.
go back to reference Stefanov TS, Temelkova-Kurktschiev TS: The metabolic syndrome in Bulgaria. Folia Med (Plovdiv). 2011, 53 (4): 5-14. Stefanov TS, Temelkova-Kurktschiev TS: The metabolic syndrome in Bulgaria. Folia Med (Plovdiv). 2011, 53 (4): 5-14.
16.
go back to reference Cooper AJ, Brage S, Ekelund U, Wareham NJ, Griffin SJ, Simmons RK: Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia. 2014, 57 (1): 73-82. 10.1007/s00125-013-3069-8.CrossRefPubMed Cooper AJ, Brage S, Ekelund U, Wareham NJ, Griffin SJ, Simmons RK: Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia. 2014, 57 (1): 73-82. 10.1007/s00125-013-3069-8.CrossRefPubMed
17.
go back to reference Meng W, Zhang C, Zhang Q, Song X, Lin H, Zhang D, Zhang Y, Zhu Z, Wu S, Liu Y, Tang F, Yang X, Xue F: Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. PLoS One. 2012, 7 (11): e49875-10.1371/journal.pone.0049875.CrossRefPubMedPubMedCentral Meng W, Zhang C, Zhang Q, Song X, Lin H, Zhang D, Zhang Y, Zhu Z, Wu S, Liu Y, Tang F, Yang X, Xue F: Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. PLoS One. 2012, 7 (11): e49875-10.1371/journal.pone.0049875.CrossRefPubMedPubMedCentral
18.
go back to reference Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, Zhang Y, Zhu Z, Tang F, Liu L, Yang X, Xue F: A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health. 2012, 12: 419-10.1186/1471-2458-12-419.CrossRefPubMedPubMedCentral Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, Zhang Y, Zhu Z, Tang F, Liu L, Yang X, Xue F: A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health. 2012, 12: 419-10.1186/1471-2458-12-419.CrossRefPubMedPubMedCentral
19.
go back to reference Tao L, Li X, Zhu H, Gao Y, Luo Y, Wang W, Wang Z, Chen D, Wu L, Guo X: Association between gamma-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. Int J Environ Res Public Health. 2013, 10 (11): 5523-5540. 10.3390/ijerph10115523.CrossRefPubMedPubMedCentral Tao L, Li X, Zhu H, Gao Y, Luo Y, Wang W, Wang Z, Chen D, Wu L, Guo X: Association between gamma-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. Int J Environ Res Public Health. 2013, 10 (11): 5523-5540. 10.3390/ijerph10115523.CrossRefPubMedPubMedCentral
20.
go back to reference Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-Gonzalez M, Gutierrez NG, Martinez U: Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract. 2014, 8 (1): e79-e87. 10.1016/j.orcp.2012.08.191.CrossRefPubMed Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-Gonzalez M, Gutierrez NG, Martinez U: Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract. 2014, 8 (1): e79-e87. 10.1016/j.orcp.2012.08.191.CrossRefPubMed
21.
go back to reference Hwang LC, Bai CH, You SL, Sun CA, Chen CJ: Description and prediction of the development of metabolic syndrome: a longitudinal analysis using a markov model approach. PLoS One. 2013, 8 (6): e67436-10.1371/journal.pone.0067436.CrossRefPubMedPubMedCentral Hwang LC, Bai CH, You SL, Sun CA, Chen CJ: Description and prediction of the development of metabolic syndrome: a longitudinal analysis using a markov model approach. PLoS One. 2013, 8 (6): e67436-10.1371/journal.pone.0067436.CrossRefPubMedPubMedCentral
22.
go back to reference Haring R, Rosvall M, Volker U, Volzke H, Kroemer H, Nauck M, Wallaschofski H: A network-based approach to visualize prevalence and progression of metabolic syndrome components. PLoS One. 2012, 7 (6): e39461-10.1371/journal.pone.0039461.CrossRefPubMedPubMedCentral Haring R, Rosvall M, Volker U, Volzke H, Kroemer H, Nauck M, Wallaschofski H: A network-based approach to visualize prevalence and progression of metabolic syndrome components. PLoS One. 2012, 7 (6): e39461-10.1371/journal.pone.0039461.CrossRefPubMedPubMedCentral
23.
go back to reference Sonnenberg FA, Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making. 1993, 13 (4): 322-338. 10.1177/0272989X9301300409.CrossRefPubMed Sonnenberg FA, Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making. 1993, 13 (4): 322-338. 10.1177/0272989X9301300409.CrossRefPubMed
24.
go back to reference Lu YH, Lu JM, Wang SY, Li CL, Liu LS, Zheng RP, Tian H, Wang XL, Yang LJ, Zhang YQ, Pan CY: Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi. 2006, 86 (6): 386-389.PubMed Lu YH, Lu JM, Wang SY, Li CL, Liu LS, Zheng RP, Tian H, Wang XL, Yang LJ, Zhang YQ, Pan CY: Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi. 2006, 86 (6): 386-389.PubMed
25.
go back to reference Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, Lee WM, Gern JE, Lemanske RJ: Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012, 185 (3): 281-285. 10.1164/rccm.201104-0660OC.CrossRefPubMedPubMedCentral Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, Lee WM, Gern JE, Lemanske RJ: Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012, 185 (3): 281-285. 10.1164/rccm.201104-0660OC.CrossRefPubMedPubMedCentral
26.
go back to reference Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, Harmsen WS, Zinsmeister AR: Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999, 117 (1): 49-57. 10.1016/S0016-5085(99)70549-4.CrossRefPubMed Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, Harmsen WS, Zinsmeister AR: Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999, 117 (1): 49-57. 10.1016/S0016-5085(99)70549-4.CrossRefPubMed
27.
go back to reference Silverstein MD, Albert DA, Hadler NM, Ropes MW: Prognosis in SLE: comparison of Markov model to life table analysis. J Clin Epidemiol. 1988, 41 (7): 623-633. 10.1016/0895-4356(88)90114-X.CrossRefPubMed Silverstein MD, Albert DA, Hadler NM, Ropes MW: Prognosis in SLE: comparison of Markov model to life table analysis. J Clin Epidemiol. 1988, 41 (7): 623-633. 10.1016/0895-4356(88)90114-X.CrossRefPubMed
28.
go back to reference Scuteri A, Morrell CH, Najjar SS, Muller D, Andres R, Ferrucci L, Lakatta EG: Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2009, 64 (5): 590-598.CrossRefPubMed Scuteri A, Morrell CH, Najjar SS, Muller D, Andres R, Ferrucci L, Lakatta EG: Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2009, 64 (5): 590-598.CrossRefPubMed
29.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.
30.
go back to reference Chedraui P, Escobar GS, Perez-Lopez FR, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T: Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas. 2014, 77 (4): 370-374. 10.1016/j.maturitas.2014.01.014.CrossRefPubMed Chedraui P, Escobar GS, Perez-Lopez FR, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T: Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas. 2014, 77 (4): 370-374. 10.1016/j.maturitas.2014.01.014.CrossRefPubMed
31.
go back to reference Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Manas LR, Raso FU, Muiesan ML, Ryliskyte L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM: Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol. 2014, doi:10.1177/2047487314525529 Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Manas LR, Raso FU, Muiesan ML, Ryliskyte L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM: Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol. 2014, doi:10.1177/2047487314525529
32.
go back to reference Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444 (7121): 881-887. 10.1038/nature05488.CrossRefPubMed
33.
34.
go back to reference Liu Y, Wang D, Li D, Sun R, Xia M: Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014, 6 (1): 25-10.1186/1758-5996-6-25.CrossRefPubMedPubMedCentral Liu Y, Wang D, Li D, Sun R, Xia M: Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014, 6 (1): 25-10.1186/1758-5996-6-25.CrossRefPubMedPubMedCentral
35.
go back to reference Kim JH, Baik HW, Yoon YS, Joung HJ, Park JS, Park SJ, Jang EJ, Park SW, Kim SJ, Kim MJ, Jeon DO, Cho HJ, Lee SJ, Im SG, Jang SK: Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome. Korean J Intern Med. 2014, 29 (1): 31-39. 10.3904/kjim.2014.29.1.31.CrossRefPubMedPubMedCentral Kim JH, Baik HW, Yoon YS, Joung HJ, Park JS, Park SJ, Jang EJ, Park SW, Kim SJ, Kim MJ, Jeon DO, Cho HJ, Lee SJ, Im SG, Jang SK: Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome. Korean J Intern Med. 2014, 29 (1): 31-39. 10.3904/kjim.2014.29.1.31.CrossRefPubMedPubMedCentral
36.
go back to reference Landsberg L, Molitch M: Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens. 2004, 26 (7–8): 621-628.CrossRefPubMed Landsberg L, Molitch M: Diabetes and hypertension: pathogenesis, prevention and treatment. Clin Exp Hypertens. 2004, 26 (7–8): 621-628.CrossRefPubMed
37.
go back to reference Cheung BM: The hypertension-diabetes continuum. J Cardiovasc Pharmacol. 2010, 55 (4): 333-339. 10.1097/FJC.0b013e3181d26430.CrossRefPubMed Cheung BM: The hypertension-diabetes continuum. J Cardiovasc Pharmacol. 2010, 55 (4): 333-339. 10.1097/FJC.0b013e3181d26430.CrossRefPubMed
38.
go back to reference Bardini G, Rotella CM, Giannini S: Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012, 9 (2–3): 82-93.CrossRefPubMedPubMedCentral Bardini G, Rotella CM, Giannini S: Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012, 9 (2–3): 82-93.CrossRefPubMedPubMedCentral
39.
go back to reference Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2010, 375 (9710): 181-183. 10.1016/S0140-6736(09)61794-3.CrossRefPubMed Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2010, 375 (9710): 181-183. 10.1016/S0140-6736(09)61794-3.CrossRefPubMed
Metadata
Title
Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model
Authors
Xiaoxiao Chen
Qicai Chen
Lili Chen
Pengpeng Zhang
Juan Xiao
Shumei Wang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-1033

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue